BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25624444)

  • 1. PDK1 orchestrates early NK cell development through induction of E4BP4 expression and maintenance of IL-15 responsiveness.
    Yang M; Li D; Chang Z; Yang Z; Tian Z; Dong Z
    J Exp Med; 2015 Feb; 212(2):253-65. PubMed ID: 25624444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full Activation of Kinase Protein Kinase B by Phosphoinositide-Dependent Protein Kinase-1 and Mammalian Target of Rapamycin Complex 2 Is Required for Early Natural Killer Cell Development and Survival.
    He J; Zhao J; Quan Y; Hou X; Yang M; Dong Z
    Front Immunol; 2020; 11():617404. PubMed ID: 33633735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transcription factor E4BP4 is not required for extramedullary pathways of NK cell development.
    Crotta S; Gkioka A; Male V; Duarte JH; Davidson S; Nisoli I; Brady HJ; Wack A
    J Immunol; 2014 Mar; 192(6):2677-88. PubMed ID: 24534532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage-specific requirement of kinase PDK1 for NK cells development and activation.
    He J; Wang Y; Liu T; Liu G; Chen S; Li Q; Quan Y; Yang H; Feng J; Wang S; Yang M; Dong Z
    Cell Death Differ; 2019 Oct; 26(10):1918-1928. PubMed ID: 30622306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development.
    Gascoyne DM; Long E; Veiga-Fernandes H; de Boer J; Williams O; Seddon B; Coles M; Kioussis D; Brady HJ
    Nat Immunol; 2009 Oct; 10(10):1118-24. PubMed ID: 19749763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development.
    Tang PM; Zhou S; Meng XM; Wang QM; Li CJ; Lian GY; Huang XR; Tang YJ; Guan XY; Yan BP; To KF; Lan HY
    Nat Commun; 2017 Mar; 8():14677. PubMed ID: 28262747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Levels of Control Determine How E4bp4/Nfil3 Regulates NK Cell Development.
    Kostrzewski T; Borg AJ; Meng Y; Filipovic I; Male V; Wack A; DiMaggio PA; Brady HJM
    J Immunol; 2018 Feb; 200(4):1370-1381. PubMed ID: 29311361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic IL-15 Stimulation and Impaired mTOR Signaling and Metabolism in Natural Killer Cells During Acute Myeloid Leukemia.
    Bou-Tayeh B; Laletin V; Salem N; Just-Landi S; Fares J; Leblanc R; Balzano M; Kerdiles YM; Bidaut G; Hérault O; Olive D; Aurrand-Lions M; Walzer T; Nunès JA; Fauriat C
    Front Immunol; 2021; 12():730970. PubMed ID: 34975835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcription factor E4bp4/Nfil3 controls commitment to the NK lineage and directly regulates Eomes and Id2 expression.
    Male V; Nisoli I; Kostrzewski T; Allan DS; Carlyle JR; Lord GM; Wack A; Brady HJ
    J Exp Med; 2014 Apr; 211(4):635-42. PubMed ID: 24663216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cell development requires Tsc1-dependent negative regulation of IL-15-triggered mTORC1 activation.
    Yang M; Chen S; Du J; He J; Wang Y; Li Z; Liu G; Peng W; Zeng X; Li D; Xu P; Guo W; Chang Z; Wang S; Tian Z; Dong Z
    Nat Commun; 2016 Sep; 7():12730. PubMed ID: 27601261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.
    Viel S; Marçais A; Guimaraes FS; Loftus R; Rabilloud J; Grau M; Degouve S; Djebali S; Sanlaville A; Charrier E; Bienvenu J; Marie JC; Caux C; Marvel J; Town L; Huntington ND; Bartholin L; Finlay D; Smyth MJ; Walzer T
    Sci Signal; 2016 Feb; 9(415):ra19. PubMed ID: 26884601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy.
    Tan J; Li Z; Lee PL; Guan P; Aau MY; Lee ST; Feng M; Lim CZ; Lee EY; Wee ZN; Lim YC; Karuturi RK; Yu Q
    Cancer Discov; 2013 Oct; 3(10):1156-71. PubMed ID: 23887393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTORC1 and mTORC2 coordinate early NK cell development by differentially inducing E4BP4 and T-bet.
    Li D; Wang Y; Yang M; Dong Z
    Cell Death Differ; 2021 Jun; 28(6):1900-1909. PubMed ID: 33462410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nfil3-independent lineage maintenance and antiviral response of natural killer cells.
    Firth MA; Madera S; Beaulieu AM; Gasteiger G; Castillo EF; Schluns KS; Kubo M; Rothman PB; Vivier E; Sun JC
    J Exp Med; 2013 Dec; 210(13):2981-90. PubMed ID: 24277151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.
    Mao Y; van Hoef V; Zhang X; Wennerberg E; Lorent J; Witt K; Masvidal L; Liang S; Murray S; Larsson O; Kiessling R; Lundqvist A
    Blood; 2016 Sep; 128(11):1475-89. PubMed ID: 27465917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential role for interleukin-15 in the regulation of human natural killer cell survival.
    Carson WE; Fehniger TA; Haldar S; Eckhert K; Lindemann MJ; Lai CF; Croce CM; Baumann H; Caligiuri MA
    J Clin Invest; 1997 Mar; 99(5):937-43. PubMed ID: 9062351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription factor Rfx7 limits metabolism of NK cells and promotes their maintenance and immunity.
    Castro W; Chelbi ST; Niogret C; Ramon-Barros C; Welten SPM; Osterheld K; Wang H; Rota G; Morgado L; Vivier E; Raeber ME; Boyman O; Delorenzi M; Barras D; Ho PC; Oxenius A; Guarda G
    Nat Immunol; 2018 Aug; 19(8):809-820. PubMed ID: 29967452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-17 constrains natural killer cell activity by restraining IL-15-driven cell maturation via SOCS3.
    Wang X; Sun R; Hao X; Lian ZX; Wei H; Tian Z
    Proc Natl Acad Sci U S A; 2019 Aug; 116(35):17409-17418. PubMed ID: 31405974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDK1 promotes tumor growth and metastasis in a spontaneous breast cancer model.
    Du J; Yang M; Chen S; Li D; Chang Z; Dong Z
    Oncogene; 2016 Jun; 35(25):3314-23. PubMed ID: 26455327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shp-2 is critical for ERK and metabolic engagement downstream of IL-15 receptor in NK cells.
    Niogret C; Miah SMS; Rota G; Fonta NP; Wang H; Held W; Birchmeier W; Sexl V; Yang W; Vivier E; Ho PC; Brossay L; Guarda G
    Nat Commun; 2019 Mar; 10(1):1444. PubMed ID: 30926899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.